
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Forecast from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/forecast/topic/4339/</link>
        <description>Articles tagged with Forecast from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Still no jetpacks, but telemedicine, personalized medicine are the future, says study </title>
          <description>Diabetes will be the 800-pound gorilla in healthcare for the foreseeable future, according to a crystal ball-gazing white paper from Euro RSCG which pegs the rise of telemedicine, a wave of &quot;cyberchondria&quot; and soaring rates of medical tourism as among the emerging trends reshaping the practice of medicine.</description>
          <link>http://www.mmm-online.com/still-no-jetpacks-but-telemedicine-personalized-medicine-are-the-future-says-study/article/218173/</link>
          <pubDate>Mon, 05 Dec 2011 20:39:12 GMT</pubDate>
          <itunes:summary>Diabetes will be the 800-pound gorilla in healthcare for the foreseeable future, according to a crystal ball-gazing white paper from Euro RSCG which pegs the rise of telemedicine, a wave of &quot;cyberchondria&quot; and soaring rates of medical tourism as among the emerging trends reshaping the practice of medicine.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: EvaluatePharma and Citeline</title>
          <description>Years after generic competition begins eroding Lipitor revenues (and RA biologic Humira overtakes it as the world&apos;s biggest selling drug), Pfizer will still be the industry&apos;s sales leader, but Sanofi and Novartis will run closely behind, according to EvaluatePharma&apos;s World Preview 2016.</description>
          <link>http://www.mmm-online.com/company-news-evaluatepharma-and-citeline/article/206296/</link>
          <pubDate>Tue, 28 Jun 2011 18:18:34 GMT</pubDate>
          <itunes:summary>Years after generic competition begins eroding Lipitor revenues (and RA biologic Humira overtakes it as the world&apos;s biggest selling drug), Pfizer will still be the industry&apos;s sales leader, but Sanofi and Novartis will run closely behind, according to EvaluatePharma&apos;s World Preview 2016.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Stronger growth for global pharma in 2011, says IMS</title>
          <description>Global pharma market growth will pick up steam in 2011, with growth of 5%-7% to $880 billion, over 4%-5% growth in 2010, according to IMS Health.</description>
          <link>http://www.mmm-online.com/stronger-growth-for-global-pharma-in-2011-says-ims/article/180551/</link>
          <pubDate>Thu, 07 Oct 2010 14:45:26 GMT</pubDate>
          <itunes:summary>Global pharma market growth will pick up steam in 2011, with growth of 5%-7% to $880 billion, over 4%-5% growth in 2010, according to IMS Health.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>What&apos;s behind Humira&apos;s bullish forecast?</title>
          <description>A report predicting that Humira will become the world&apos;s biggest product in two years&apos; time generated positive news for the Abbott Labs arthritis drug. Several factors are driving the bullish forecast.</description>
          <link>http://www.mmm-online.com/whats-behind-humiras-bullish-forecast/article/169449/</link>
          <pubDate>Tue, 04 May 2010 19:45:07 GMT</pubDate>
          <itunes:summary>A report predicting that Humira will become the world&apos;s biggest product in two years&apos; time generated positive news for the Abbott Labs arthritis drug. Several factors are driving the bullish forecast.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Global drug sales to grow 5%-8% through 2014 despite patent losses, says IMS</title>
          <description>Global sales of pharmaceuticals will grow at a rate of 5%-8% annually over the next five years, IMS Health forecasts -- even as products with sales of more than $142 billion lose patent protection in top markets, reducing drug spending by $80-$100 billion.</description>
          <link>http://www.mmm-online.com/global-drug-sales-to-grow-5-8-through-2014-despite-patent-losses-says-ims/article/168368/</link>
          <pubDate>Tue, 20 Apr 2010 14:40:39 GMT</pubDate>
          <itunes:summary>Global sales of pharmaceuticals will grow at a rate of 5%-8% annually over the next five years, IMS Health forecasts -- even as products with sales of more than $142 billion lose patent protection in top markets, reducing drug spending by $80-$100 billion.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pharma resilient during economic slog, says IMS Health</title>
          <description>The global market for pharmaceuticals is expected to grow by 4%-6% in 2010 - exceeding $825 billion - due in part to near-term growth in the US, according to an IMS Health forecast.</description>
          <link>http://www.mmm-online.com/pharma-resilient-during-economic-slog-says-ims-health/article/151820/</link>
          <pubDate>Thu, 08 Oct 2009 17:23:05 GMT</pubDate>
          <itunes:summary>The global market for pharmaceuticals is expected to grow by 4%-6% in 2010 - exceeding $825 billion - due in part to near-term growth in the US, according to an IMS Health forecast.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  